Particle production azimuthal asymmetries in a clustering of color sources model

The collective interactions of many partons in the first stage of the collisions is the usual accepted explanation of the sizable elliptical flow. The clustering of color sources provides a framework of partonic interactions. In this scheme, we show a reasonable agreement with RHIC data for pT<1.5 GeV/c in both the dependence of v2 transverse momentum and in the shape of the nuclear modified factor on the azimuthal angle for different centralities. We show the predictions at LHC energies for Pb-Pb. In the case of proton-proton collisions a sizable v2 is obtained at this energy.Comment: To appear in Journal of Physics

Preformed and regenerated phosphate in ocean general circulation models: can right total concentrations be wrong?

Phosphate distributions simulated by seven state-of-the-art biogeochemical ocean circulation models are evaluated against observations of global ocean nutrient distributions. The biogeochemical models exhibit different structural complexities, ranging from simple nutrient-restoring to multi-nutrient NPZD type models. We evaluate the simulations using the observed volume distribution of phosphate. The errors in these simulated volume class distributions are significantly larger when preformed phosphate (or regenerated phosphate) rather than total phosphate is considered. Our analysis reveals that models can achieve similarly good fits to observed total phosphate distributions for a very different partitioning into preformed and regenerated nutrient components. This has implications for the strength and potential climate sensitivity of the simulated biological carbon pump. We suggest complementing the use of total nutrient distributions for assessing model skill by an evaluation of the respective preformed and regenerated nutrient components

Measurement of zero degree single photon energy spectra for sqrt(s) = 7TeV proton-proton collisions at LHC

In early 2010, the Large Hadron Collider forward (LHCf) experiment measured very forward neutral particle spectra in LHC proton-proton collisions. From a limited data set taken under the best beam conditions (low beam-gas background and low occurance of pile-up events), the single photon spectra at sqrt(s)=7TeV and pseudo-rapidity (eta) ranges from 8.81 to 8.99 and from 10.94 to infinity were obtained for the first time and are reported in this paper. The spectra from two independent LHCf detectors are consistent with one another and serve as a cross check of the data. The photon spectra are also compared with the predictions of several hadron interaction models that are used extensively for modeling ultra high energy cosmic ray showers. Despite conservative estimates for the systematic errors, none of the models agree perfectly with the measurements. A notable difference is found between the data and the DPMJET 3.04 and PYTHIA 8.145 hadron interaction models above 2TeV where the models predict higher photon yield than the data. The QGSJET II-03 model predicts overall lower photon yield than the data, especially above 2TeV in the rapidity range 8.81<eta<8.99

Sharpening Low-Energy, Standard-Model Tests via Correlation Coefficients in Neutron Beta-Decay

The correlation coefficients a, A, and B in neutron beta-decay are proportional to the ratio of the axial-vector to vector weak coupling constants, g_A/g_V, to leading recoil order. With the advent of the next generation of neutron decay experiments, the recoil-order corrections to these expressions become experimentally accessible, admitting a plurality of Standard Model (SM) tests. The measurement of both a and A, e.g., allows one to test the conserved-vector-current (CVC) hypothesis and to search for second-class currents (SCC) independently. The anticipated precision of these measurements suggests that the bounds on CVC violation and SCC from studies of nuclear beta-decay can be qualitatively bettered. Departures from SM expectations can be interpreted as evidence for non-V-A currents.Comment: 4 pages, REVTeX, intro. broadened, typos fixed, to appear in PR

Higher-Derivative Boson Field Theories and Constrained Second-Order Theories

As an alternative to the covariant Ostrogradski method, we show that higher-derivative relativistic Lagrangian field theories can be reduced to second differential-order by writing them directly as covariant two-derivative theories involving Lagrange multipliers and new fields. Despite the intrinsic non-covariance of the Dirac's procedure used to deal with the constraints, the explicit Lorentz invariance is recovered at the end. We develop this new setting on the grounds of a simple scalar model and then its applications to generalized electrodynamics and higher-derivative gravity are worked out. For a wide class of field theories this method is better suited than Ostrogradski's for a generalization to 2n-derivative theoriesComment: 31 pages, Plain Te

Electrostatic potential in a superconductor

The electrostatic potential in a superconductor is studied. To this end Bardeen's extension of the Ginzburg-Landau theory to low temperatures is used to derive three Ginzburg-Landau equations - the Maxwell equation for the vector potential, the Schroedinger equation for the wave function and the Poisson equation for the electrostatic potential. The electrostatic and the thermodynamic potential compensate each other to a great extent resulting into an effective potential acting on the superconducting condensate. For the Abrikosov vortex lattice in Niobium, numerical solutions are presented and the different contributions to the electrostatic potential and the related charge distribution are discussed.Comment: 19 pages, 11 figure

The quantum state vector in phase space and Gabor's windowed Fourier transform

Representations of quantum state vectors by complex phase space amplitudes, complementing the description of the density operator by the Wigner function, have been defined by applying the Weyl-Wigner transform to dyadic operators, linear in the state vector and anti-linear in a fixed `window state vector'. Here aspects of this construction are explored, with emphasis on the connection with Gabor's `windowed Fourier transform'. The amplitudes that arise for simple quantum states from various choices of window are presented as illustrations. Generalized Bargmann representations of the state vector appear as special cases, associated with Gaussian windows. For every choice of window, amplitudes lie in a corresponding linear subspace of square-integrable functions on phase space. A generalized Born interpretation of amplitudes is described, with both the Wigner function and a generalized Husimi function appearing as quantities linear in an amplitude and anti-linear in its complex conjugate. Schr\"odinger's time-dependent and time-independent equations are represented on phase space amplitudes, and their solutions described in simple cases.Comment: 36 pages, 6 figures. Revised in light of referees' comments, and further references adde

Squeezed States of the Generalized Minimum Uncertainty State for the Caldirola-Kanai Hamiltonian

We show that the ground state of the well-known pseudo-stationary states for the Caldirola-Kanai Hamiltonian is a generalized minimum uncertainty state, which has the minimum allowed uncertainty $\Delta q \Delta p = \hbar \sigma_0/2$, where $\sigma_0 (\geq 1)$ is a constant depending on the damping factor and natural frequency. The most general symmetric Gaussian states are obtained as the one-parameter squeezed states of the pseudo-stationary ground state. It is further shown that the coherent states of the pseudo-stationary ground state constitute another class of the generalized minimum uncertainty states.Comment: RevTex4, 9 pages, no fingure; to be published in Journal of Physics

Potent antiviral activity against HSV-1 and SARS-CoV-2 by antimicrobial peptoids

Viral infections, such as those caused by Herpes Simplex Virus-1 (HSV-1) and SARS-CoV-2, affect millions of people each year. However, there are few antiviral drugs that can effectively treat these infections. The standard approach in the development of antiviral drugs involves the identification of a unique viral target, followed by the design of an agent that addresses that target. Antimicrobial peptides (AMPs) represent a novel source of potential antiviral drugs. AMPs have been shown to inactivate numerous different enveloped viruses through the disruption of their viral envelopes. However, the clinical development of AMPs as antimicrobial therapeutics has been hampered by a number of factors, especially their enzymatically labile structure as peptides. We have examined the antiviral potential of peptoid mimics of AMPs (sequence-specific N-substituted glycine oligomers). These peptoids have the distinct advantage of being insensitive to proteases, and also exhibit increased bioavailability and stability. Our results demonstrate that several peptoids exhibit potent in vitro antiviral activity against both HSV-1 and SARS-CoV-2 when incubated prior to infection. In other words, they have a direct effect on the viral structure, which appears to render the viral particles non-infective. Visualization by cryo-EM shows viral envelope disruption similar to what has been observed with AMP activity against other viruses. Furthermore, we observed no cytotoxicity against primary cultures of oral epithelial cells. These results suggest a common or biomimetic mechanism, possibly due to the differences between the phospholipid head group makeup of viral envelopes and host cell membranes, thus underscoring the potential of this class of molecules as safe and effective broad-spectrum antiviral agents. We discuss how and why differing molecular features between 10 peptoid candidates may affect both antiviral activity and selectivity

Immune Function and Muscle Adaptations to Resistance exercise in Older Adults: Study Protocol for a Randomized Controlled Trial of a Nutritional Supplement

BACKGROUND: Immune function may influence the ability of older adults to maintain or improve muscle mass, strength, and function during aging. Thus, nutritional supplementation that supports the immune system could complement resistance exercise as an intervention for age-associated muscle loss. The current study will determine the relationship between immune function and exercise training outcomes for older adults who consume a nutritional supplement or placebo during resistance training and post-training follow-up. The supplement was chosen due to evidence suggesting its ingredients [arginine (Arg), glutamine (Gln), and β-hydroxy β-methylbutyrate (HMB)] can improve immune function, promote muscle growth, and counteract muscle loss. METHODS/DESIGN: Veterans (age 60 to 80 yrs, N = 50) of the United States military will participate in a randomized double-blind placebo-controlled trial of consumption of a nutritional supplement or placebo during completion of three study objectives: 1) determine if 2 weeks of supplementation improve immune function measured as the response to vaccination and systemic and cellular responses to acute resistance exercise; 2) determine if supplementation during 36 sessions of resistance training boosts gains in muscle size, strength, and function; and 3) determine if continued supplementation for 26 weeks post-training promotes retention of training-induced gains in muscle size, strength, and function. Analyses of the results for these objectives will determine the relationship between immune function and the training outcomes. Participants will undergo nine blood draws and five muscle (vastus lateralis) biopsies so that the effects of the supplement on immune function and the systemic and cellular responses to exercise can be measured. DISCUSSION: Exercise has known effects on immune function. However, the study will attempt to modulate immune function using a nutritional supplement and determine the effects on training outcomes. The study will also examine post-training benefit retention, an important issue for older adults, usually omitted from exercise studies. The study will potentially advance our understanding of the mechanisms of muscle gain and loss in older adults, but more importantly, a nutritional intervention will be evaluated as a complement to exercise for supporting muscle health during aging. TRIAL REGISTRATION: Clinicaltrials.gov identifier: NCT02261961, registration date 10 June 2014, recruitment active